Cited by 3,720Pregnancy and preeclampsia studiesNeurological Complications and SyndromesAngiogenesis and VEGF in Cancer

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Circulating Angiogenic Factors and the Risk of Preeclampsia

Open access

Levine, Richard J., Maynard, Sharon E., Qian, Cong, Lim, Kee-Hak, England, Lucinda J., Yu, Kai F., Schisterman, Enrique F., Thadhani, Ravi, Sachs, Benjamin P., Epstein, Franklin H., Sibai, Baha M., Sukhatme, Vikas P., Karumanchi, S. Ananth·2004·New England Journal of Medicine

DOI 10.1056/nejmoa031884

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The cause of preeclampsia remains unclear. Limited data suggest that excess circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor (PlGF) and vascular endothelial growth factor (VEGF), may have a pathogenic role. METHODS: We performed a nested case-control study within the Calcium for Preeclampsia Prevention trial, which involved healthy nulliparous women. Each woman with preeclampsia was matched to one normotensive control. A total of 120 pairs of women were randomly chosen. Serum concentrations of angiogenic factors (total sFlt-1, free PlGF, and free VEGF) were measured throughout pregnancy; there were a total of 655 serum specimens. The data were analyzed cross-sectionally within intervals of gestational age and according to the time before the onset of preeclampsia. RESULTS: During the last two months of pregnancy in the normotensive controls, the level of sFlt-1 increased and the level of PlGF decreased. These changes occurred earlier and were more pronounced in the women in whom preeclampsia later developed. The sFlt-1 level increased beginning approximately five weeks before the onset of preeclampsia. At the onset of clinical disease, the mean serum level in the women with preeclampsia was 4382 pg per milliliter, as compared with 1643 pg per milliliter in controls with fetuses of similar gestational age (P<0.001). The PlGF levels were significantly lower in the women who later had preeclampsia than in the controls beginning at 13 to 16 weeks of gestation (mean, 90 pg per milliliter vs. 142 pg per milliliter, P=0.01), with the greatest difference occurring during the weeks before the onset of preeclampsia, coincident with the increase in the sFlt-1 level. Alterations in the levels of sFlt-1 and free PlGF were greater in women with an earlier onset of preeclampsia and in women in whom preeclampsia was associated with a small-for-gestational-age infant. CONCLUSIONS: Increased levels of sFlt-1 and reduced levels of PlGF predict the subsequent development of preeclampsia.

Integrity signals

Registry

Crossref · 10.1056/nejmoa031884

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citation
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
Yang, J. C., Haworth, L. R., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,704
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
Kabbinavar, F. F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Liebérman, G., Griffing, S., & Bergsland, E. K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,711
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
Eremina, V., Sood, M. M., Haigh, J. J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H. P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,308
Pathogenesis and genetics of pre-eclampsia
Roberts, J., & Cooper, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03577-7 · Cited by 1,279
Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?
Zhou, Y., Damsky, C. H., & Fisher, S. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119388 · Cited by 937
Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome
Zhou, Y., McMaster, M., Woo, K., Janatpour, M. J., Perry, J., Kärpänen, T., Alitalo, K. K., Damsky, C. H., & Fisher, S. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62567-9 · Cited by 643
Trial of Calcium to Prevent Preeclampsia
Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370201 · Cited by 634
Self-citation
Pre-eclampsia
Walker, J. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02800-2 · Cited by 519
Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences
Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J.-F., Pignon, M.-R., Noël, A., Schaaps, J., CABROL, D., Frankenne, F., & Foidart, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030528 · Cited by 465

Flagged first, then by citations

Show all 24 references

Sorted by citations

Items 501–600 of 1,011

Could uric acid have a pathogenic role in pre-eclampsia?
Martin, A. C., & Brown, M. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.125 · Cited by 96
All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study
Vigneau, C. M., Lorcy, N., Dolley‐Hitze, T., Jouan, F., Arlot‐Bonnemains, Y., Laguerre, B., Verhoest, G., Goujon, J. M., Belaud‐Rotureau, M., & Rioux-Leclercq, N. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft465 · Cited by 96
Angiogenic Biomarkers in Preeclampsia
Burwick, R. M., & Rodriguez, M. H. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005532 · Cited by 96
New Developments in the Pathogenesis of Preeclampsia
Naljayan, M. V., & Karumanchi, S. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.02.003 · Cited by 97
Self-citation
Preeclampsia and the anti-angiogenic state
Agarwal, I., & Karumanchi, S. A. (2010) · Pregnancy Hypertension · doi:10.1016/j.preghy.2010.10.007 · Cited by 95
Self-citation
High Altitude During Pregnancy
Julian, C. G. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.10.008 · Cited by 94
Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis
Masuyama, H., Suwaki, N., Nakatsukasa, H., Masumoto, A., Tateishi, Y., & Hiramatrsu, Y. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.08.034 · Cited by 93
Recent insights into the pathophysiology of preeclampsia
George, E. M., & Granger, J. P. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.45 · Cited by 95
Circulating angiogenic and antiangiogenic factors in women with eclampsia
Vaisbuch, E., Whitty, J. E., Hassan, S. S., Romero, R. J., Kusanovic, J. P., Cotton, D. B., Sorokin, Y., & Karumanchi, S. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.049 · Cited by 93
Self-citation
Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of Preeclampsia
Xia, Y., Ramin, S. M., & Kellems, R. E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091322 · Cited by 94
Pathophysiology of Preeclampsia: The Role of Exosomes
Matsubara, K., Matsubara, Y., Uchikura, Y., & Sugiyama, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052572 · Cited by 97
Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria.
Uneke, C. J. (2007) · PubMed Central · Cited by 92
The placental component in early‐onset and late‐onset preeclampsia in relation to fetal growth restriction
Kovo, M., Schreiber, L., Ben‐Haroush, A., Gold, E., Golan, A., & Bar, J. (2012) · Prenatal Diagnosis · doi:10.1002/pd.3872 · Cited by 92
Autoantibody-Mediated IL-6–Dependent Endothelin-1 Elevation Underlies Pathogenesis in a Mouse Model of Preeclampsia
Zhou, C. C., Irani, R. A., Dai, Y., Blackwell, S. C., Hicks, J. M., Ramin, S. M., Kellems, R. E., & Xia, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004026 · Cited by 92
Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia
Molvarec, A., Szarka, A., Walentin, S., Szücs, E., Nagy, B., & Rigó, J. J. (2010) · Hypertension Research · doi:10.1038/hr.2010.92 · Cited by 91
Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies
Wu, Y., Xiong, X., Fraser, W. D., & Luo, Z. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.18 · Cited by 91
Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
Ohkuchi, A., Hirashima, C., Suzuki, H., Takahashi, K., Yoshida, M., Matsubara, S., & Suzuki, M. (2010) · Hypertension Research · doi:10.1038/hr.2010.15 · Cited by 91
An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia
Park, C., Park, J. S., Shim, S. S., Jun, J. K., Yoon, B. H., & Romero, R. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.06.033 · Cited by 91
Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm Preeclampsia
Powers, R. W., Roberts, J. M., Plymire, D. A., Pucci, D., Datwyler, S. A., Laird, D. M., Sogin, D. C., Jeyabalan, A., Hubel, C. A., & Gandley, R. E. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191213 · Cited by 93
Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia
Egeland, G. M., Klungsøyr, K., Øyen, N., Tell, G. S., Næss, Ø., & Skjærven, R. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07099 · Cited by 91
Hypertension in Pregnancy: Natural History and Treatment Options
Foo, L. F., Tay, J., Lees, C., McEniery, C. M., & Wilkinson, I. B. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0545-1 · Cited by 91
Complement Activation and Thrombotic Microangiopathies
Palomo, M., Blasco, M., Molina, P., Lozano, M., Praga, M., Torramadé‐Moix, S., Martínez-Sánchez, J., Cid, J., Escolar, G., Carreras, E., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05830519 · Cited by 90
Complement in Pregnancy: A Delicate Balance
Denny, K. J., Woodruff, T. M., Taylor, S. M., & Callaway, L. K. (2012) · American Journal of Reproductive Immunology · doi:10.1111/aji.12000 · Cited by 90
Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study
Levine, R. J., VATTEN, L. J., Horowitz, G., Qian, C., Romundstad, P., Yu, K., Hollenberg, A. N., Hellevik, A. I., Åsvold, B. O., & Karumanchi, S. A. (2009) · BMJ · doi:10.1136/bmj.b4336 · Cited by 92
Self-citation
Angiogenic balance (sFlt-1/PlGF) and preeclampsia
Lecarpentier, É., & Tsatsaris, V. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.04.007 · Cited by 91
The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study
Romero, R. J., Erez, O., Maymon, E., Chaemsaithong, P., Xu, Z., Pacora, P., Chaiworapongsa, T., Done, B., Hassan, S. S., & Tarca, A. L. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.037 · Cited by 89
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes
Leaños‐Miranda, A., Navarro-Romero, C. S., Sillas-Pardo, L. J., Ramírez-Valenzuela, K. L., Isordia‐Salas, I., & Jiménez-Trejo, L. M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13348 · Cited by 94
Maternal Circulating Levels of Activin A, Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and Pre-Eclampsia
Reddy, A., Suri, S., Sargent, I. L., Redman, C. W. G., & Muttukrishna, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004453 · Cited by 90
Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays
Benton, S. J., Hu, Y., Xie, F., Kupfer, K., Lee, S., Magee, L. A., & von Dadelszen, P. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.058 · Cited by 90
The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction
Kimura, C., Watanabe, K., Iwasaki, A., Mori, T., Matsushita, H., Shinohara, K., & Wakatsuki, A. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.733766 · Cited by 93
Placental expression of VEGF family mRNA in adverse pregnancy outcomes
Andraweera, P. H., Dekker, G., Laurence, J. A., & Roberts, C. T. (2012) · Placenta · doi:10.1016/j.placenta.2012.02.013 · Cited by 89
Acute kidney injury in pregnancy-specific disorders
Prakash, J., & Ganiger, V. C. (2017) · Indian Journal of Nephrology · doi:10.4103/0971-4065.202406 · Cited by 88
Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants
Speer, P. D., Powers, R. W., Frank, M. P., Harger, G. F., Marković, N., & Roberts, J. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.052 · Cited by 88
Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study
Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Cortez, J. M., Pappas, A., Tarca, A. L., Chaemsaithong, P., Dong, Z., Yeo, L., & Hassan, S. S. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.806905 · Cited by 88
Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods
DiGiulio, D. B., Gervasi, M.-T., Romero, R. J., Mazaki‐Tovi, S., Vaisbuch, E., Kusanovic, J. P., Seok, K. S., Gómez, R., Mittal, P., Gotsch, F., et al. (2010) · Journal of Perinatal Medicine · doi:10.1515/jpm.2010.078 · Cited by 89
Placental Expression of Soluble fms-Like Tyrosine Kinase 1 is Increased in Singletons and Twin Pregnancies with Intrauterine Growth Restriction
Nevo, O., Many, A., Xu, J., Kingdom, J. C., Piccoli, E., Zamudio, S., Post, M., Bocking, A. D., Todros, T., & Caniggia, I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1042 · Cited by 88
Interleukin-11 alters placentation and causes preeclampsia features in mice
Winship, A., Koga, K., Menkhorst, E. M., Sinderen, M. L. V., Rainczuk, K., Nagai, M., Cuman, C., Yap, J., Zhang, J., Simmons, D. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515076112 · Cited by 88
Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes
Nezu, M., Souma, T., Yu, L., Sekine, H., Takahashi, N., Wei, A. Z.-S., Ito, S., Fukamizu, A., Zsengellér, Z. K., Nakamura, T., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aam5711 · Cited by 88
Self-citation
Interferon‐α and Angiogenic Dysregulation in Pregnant Lupus Patients Who Develop Preeclampsia
ANDRADE, D. C. O. D., Kim, M., Blanco, L. P., Karumanchi, S. A., Koo, G. C., Redecha, P. B., Kirou, K. A., Álvarez, Á. M., Mulla, M. J., Crow, M. K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39029 · Cited by 87
Self-citation
Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia Are More Pronounced in Women with Early Onset Severe Preeclampsia
Ohkuchi, A., Hirashima, C., Matsubara, S., Suzuki, H., Takahashi, K., Arai, F., Watanabe, T., Kario, K., & Suzuki, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.151 · Cited by 87
Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase
Sela, S., Natanson‐Yaron, S., Zcharia, E., Vlodavsky, I., Yagel, S., & Keshet, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.239665 · Cited by 88
Effect of Recombinant Placental Growth Factor 2 on Hypertension Induced by Full-Length Mouse Soluble fms-Like Tyrosine Kinase 1 Adenoviral Vector in Pregnant Mice
Suzuki, H., Ohkuchi, A., Matsubara, S., Takei, Y., Murakami, M., Shibuya, M., Suzuki, M., & Sato, Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134668 · Cited by 89
Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies
Lim, R., Acharya, R. Y., Delpachitra, P., Hobson, S. R., Sobey, C. G., Drummond, G. R., & Wallace, E. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.07.021 · Cited by 89
Phthalate metabolites and bisphenol-A in association with circulating angiogenic biomarkers across pregnancy
Ferguson, K. K., McElrath, T. F., Cantonwine, D. E., Mukherjee, B., & Meeker, J. D. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.002 · Cited by 87
Pro-Inflammatory Profile of Preeclamptic Placental Mesenchymal Stromal Cells: New Insights into the Etiopathogenesis of Preeclampsia
Rolfo, A., Giuffrida, D., Nuzzo, A. M., Pierobon, D., Cardaropoli, S., Piccoli, E., Giovarelli, M., & Todros, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059403 · Cited by 87
Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity
Palmer, K. R., Kaitu’u‐Lino, T. J., Hastie, R. M., Hannan, N. J., Ye, L., Binder, N. K., Cannon, P., Tuohey, L., Johns, T. G., Shub, A., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05883 · Cited by 90
Chronic Tempol Prevents Hypertension, Proteinuria, and Poor Feto-Placental Outcomes in BPH/5 Mouse Model of Preeclampsia
Hoffmann, D. S., Weydert, C. J. D., Lazartigues, E. D., Kutschke, W. J., Kienzle, M. F., Leach, J. E., Sharma, J. A., Sharma, R. V., & Davisson, R. L. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107219 · Cited by 88
Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension
Biró, O., Alasztics, B., Molvarec, A., Joó, J. G., Nagy, B., & Rigó, J. J. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.09.002 · Cited by 87
Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis
Gray, K. J., Saxena, R., & Karumanchi, S. A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.562 · Cited by 90
Self-citation
Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia
Ramma, W., & Ahmed, A. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.12.120 · Cited by 87
Vascular endothelial growth factors in cardiovascular medicine
Testa, U., Pannitteri, G., & Condorelli, G. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283117d37 · Cited by 88
Sera from Preeclampsia Patients Elicit Symptoms of Human Disease in Mice and Provide a Basis for an in Vitro Predictive Assay
Kalkunte, S. S., Boij, R., Norris, W. E., Friedman, J. F., Lai, Z., Kurtis, J. D., Lim, K.-H., Padbury, J. F., Matthiesen, L., & Sharma, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100475 · Cited by 86
Self-citation
Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia
Staff, A. C., Brække, K., Johnsen, G. M., Karumanchi, S. A., & Harsem, N. K. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.03.036 · Cited by 86
Self-citation
Plasma Volume Expansion in Pregnancy: Implications for Biomarkers in Population Studies
Faupel‐Badger, J. M., Hsieh, C., Troisi, R. J., Λάγιου, Π., & Potischman, N. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0311 · Cited by 86
Acute kidney injury in pregnancy: a clinical challenge
Machado, S., Figueiredo, N., Borges, A., Pais, M., Freitas, L., Moura, P., & Campos, M. (2011) · Journal of Nephrology · doi:10.5301/jn.5000013 · Cited by 86
Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes
Centlow, M., Carninci, P., Nemeth, K., Mezey, E., Brownstein, M., & Hansson, S. R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.030 · Cited by 86
Maternal Cardiovascular Dysregulation During Early Pregnancy After In Vitro Fertilization Cycles in the Absence of a Corpus Luteum
Conrad, K. P., Petersen, J. W., Chi, Y., Zhai, X., Li, M., Chiu, K.-H., Liu, J., Lingis, M., Williams, R. S., Rhoton-Vlasak, A. S., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13015 · Cited by 85
Heart Failure in Women With Hypertensive Disorders of Pregnancy
Honigberg, M. C., Riise, H. K. R., Daltveit, A. K., Tell, G. S., Sulo, G., Igland, J., Klungsøyr, K., Scott, N. S., Wood, M. J., Natarajan, P., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15654 · Cited by 85
Placental ischemia and soluble fms-like tyrosine kinase 1: Cause or consequence of preeclampsia?
Karumanchi, S. A., & Epstein, F. H. (2007) · Kidney International · doi:10.1038/sj.ki.5002281 · Cited by 88
Self-citation
Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia
Guller, S. M., Tang, Z., Ma, Y. Y., Santo, S. D., Sager, R., & Schneider, H. (2010) · Placenta · doi:10.1016/j.placenta.2010.10.011 · Cited by 87
Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression
Albonici, L., Giganti, M. G., Modesti, A., Manzari, V., & Bei, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122970 · Cited by 90
Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes
Keegan, D. A., Krey, L. C., Chang, H., & Noyes, N. L. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.08.105 · Cited by 84
A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: Evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study
Chaiworapongsa, T., Romero, R. J., Tarca, A. L., Kusanovic, J. P., Mittal, P., Kim, S. K., Gotsch, F., Erez, O., Vaisbuch, E., Mazaki‐Tovi, S., et al. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050902994838 · Cited by 85
Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre‐eclampsia
Khalil, A. A., Cooper, D. J., & Harrington, K. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01906.x · Cited by 84
Elevated sFlt1 Level and Preeclampsia with Parvovirus-Induced Hydrops
Stepan, H., & Faber, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052721 · Cited by 85
Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke
Mehendale, R., Hibbard, J. U., Fazleabas, A. T., & Leach, R. E. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.025 · Cited by 84
Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
Kim, S.-Y., Ryu, H., Yang, J.-H., Kim, M. Y., Han, J. Y., Kim, J.-O., Chung, J. H., Park, S., Lee, M., & Kim, D.-J. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.5.873 · Cited by 86
Pregnancy Outcomes after Clinical Recovery from AKI
Tangren, J. S., Powe, C. E., Ankers, E. D., Ecker, J. L., Bramham, K., Hladunewich, M., Karumanchi, S. A., & Thadhani, R. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070806 · Cited by 84
Self-citation
Obstructive Sleep Apnea in Pregnant Women: A Review of Pregnancy Outcomes and an Approach to Management
Dominguez, J. E., Krystal, A. D., & Habib, A. S. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003335 · Cited by 86
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score
Klingenberg, R., Aghlmandi, S., Räber, L., Gencer, B., Nanchen, D., Heg, D., Carballo, S., Rodondi, N., Mach, F., Windecker, S., et al. (2016) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872616684678 · Cited by 83
Endothelial dysfunction in pregnancy metabolic disorders
Echeverría, C., Eltit, F., Santibanez, J. F., Gatica, S., Cabello‐Verrugio, C., & Simón, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.009 · Cited by 84
The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia
Verlohren, S., & Dröge, L.-A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.046 · Cited by 84
Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia
Hu, X., & Zhang, L. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01184-7 · Cited by 86
Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: An update (Review)
Velegrakis, A., Kouvidi, E., Fragkiadaki, P., & Sifakis, S. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5292 · Cited by 85
Pre-eclampsia: connecting angiogenic and metabolic pathways
Shenoy, V. K., Kanasaki, K., & Kalluri, R. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.05.002 · Cited by 83
The Levels of Circulating Vascular Endothelial Growth Factor and Soluble Flt-1 in Pregnancies Complicated by Preeclampsia
Lee, E. S., Oh, M., Jung, J. W., Lim, J., Seol, H., Lee, K.-J., & Kim, H.-J. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.1.94 · Cited by 83
Small-for-gestational-age infants classified by customized or population birthweight centiles: impact of gestational age at delivery
Groom, K. M., Poppe, K., North, R. A., & McCowan, L. M. E. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.038 · Cited by 83
Targeted inhibition of complement activation prevents features of preeclampsia in mice
Qing, X., Redecha, P. B., Burmeister, M. A., Tomlinson, S., D’Agati, V. D., Davisson, R. L., & Salmon, J. E. (2010) · Kidney International · doi:10.1038/ki.2010.393 · Cited by 86
Suppression of Extravillous Trophoblast Vascular Endothelial Growth Factor Expression and Uterine Spiral Artery Invasion by Estrogen during Early Baboon Pregnancy
Bonagura, T. W., Pepe, G. J., Enders, A. C., & Albrecht, E. D. (2008) · Endocrinology · doi:10.1210/en.2008-0116 · Cited by 83
Autophagy regulation in preeclampsia: Pros and cons
Nakashima, A., Aoki, A., Kusabiraki, T., Cheng, S., Sharma, S., & Saito, S. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.08.006 · Cited by 83
Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth Restriction
Stepan, H., Kræmer, T., & Faber, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2774 · Cited by 83
Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry
Diab, A. E., Behery, M. M. E., Ebrahiem, M. A., & Shehata, A. E. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.02.016 · Cited by 86
The Vascular Marker Soluble Fms-Like Tyrosine Kinase 1 Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Ky, B., French, B. C., Ruparel, K., Sweitzer, N. K., Fang, J. C., Levy, W. C., Sawyer, D. B., & Cappola, T. P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.032 · Cited by 86
C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria
Conroy, A., Serghides, L., Finney, C., Owino, S. O., Kumar, S., Gowda, D. C., Liles, W. C., Moore, J. M., & Kain, K. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004953 · Cited by 81
Environmental Toxicant Exposure and Hypertensive Disorders of Pregnancy: Recent Findings
Kahn, L. G., & Trasande, L. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0888-5 · Cited by 84
Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction
Farah, O., Nguyen, C., Tekkatte, C., & Parast, M. M. (2020) · Placenta · doi:10.1016/j.placenta.2020.02.007 · Cited by 82
Placental Mitochondrial Function and Dysfunction in Preeclampsia
Jahan, F., Vasam, G., Green, A. E., Bainbridge, S. A., & Menzies, K. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044177 · Cited by 81
Placental weight and birthweight: does the association differ between pregnancies with and without preeclampsia?
Eskild, A., Romundstad, P., & VATTEN, L. J. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.06.003 · Cited by 81
Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia
González, C., Parra, A., Ramírez‐Peredo, J., García, C., Rivera, J. C., Macotela, Y., Aranda, J., Lemini, M., Arias, J. L. R., Ibargüengoitia, F., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700662 · Cited by 82
sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
Alfredo Perales, M., Delgado⋈, J. L., de la Calle, M., García‐Hernández, J. A., Escudero, A. I., Maza, J. M. C., Sarabia, M. D., Laíz, B., Duque, M., Navarro, M., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17373 · Cited by 83
Trophoblast-Specific Conditional Atg7 Knockout Mice Develop Gestational Hypertension
Aoki, A., Nakashima, A., Kusabiraki, T., Ono, Y., Yoshino, O., Muto, M., Kumasawa, K., Yoshimori, T., Ikawa, M., & Saito, S. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.021 · Cited by 81
The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia*
Chaiworapongsa, T., Romero, R. J., Whitten, A. E., Korzeniewski, S. J., Chaemsaithong, P., Hernandez‐Andrade, E. A., Yeo, L., & Hassan, S. S. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1048431 · Cited by 80
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy
Piccoli, G. B., Cabiddu, G., Castellino, S., Gernone, G., Santoro, D., Moroni, G. L., Spotti, D., Giacchino, F., Attini, R., Limardo, M., et al. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0390-1 · Cited by 80
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology
Cabiddu, G., Spotti, D., Gernone, G., Santoro, D., Moroni, G. L., Gregorini, G. A., Giacchino, F., Attini, R., Limardo, M., Gammaro, L., et al. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0499-x · Cited by 82
Vascular IL-10: a protective role in preeclampsia
Kalkunte, S. S., Nevers, T., Norris, W. E., & Sharma, S. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.01.009 · Cited by 80
Hypertension in Pregnancy
Vest, A. R., & Cho, L. S. (2012) · Cardiology Clinics · doi:10.1016/j.ccl.2012.04.005 · Cited by 84
Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life
Lu, F., Bytautiene, E., Tamayo, E. H., Gamble, P., Anderson, G. D., Hankins, G. D. V., Longo, M., & Saade, G. R. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.064 · Cited by 80
Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia
Huppertz, B., Meiri, H., Gizurarson, S. S., Osol, G., & Sammar, M. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt003 · Cited by 80
Adenoviral Delivery of VEGF 121 Early in Pregnancy Prevents Spontaneous Development of Preeclampsia in BPH/5 Mice
Woods, A. K., Hoffmann, D. S., Weydert, C. J. D., Butler, S. D., Zhou, Y. F., Sharma, R. V., & Davisson, R. L. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.160242 · Cited by 82
Anti–sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of Bronchopulmonary Dysplasia
Wallace, B., Peisl, A., Seedorf, G., Nowlin, T. M., Kim, C., Bosco, J., Kenniston, J. A., Keefe, D., & Abman, S. H. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1371oc · Cited by 80

Authors: Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., Sibai, B. M., Sukhatme, V. P., & Karumanchi, S. A.
Affiliations: National Institutes of Health (US)
Beth Israel Deaconess Medical Center (US)
Allied Technology (United States) (US)
Harvard University (US)
University of Cincinnati (US)
ORCID: Qian, Cong
England, Lucinda J.
Schisterman, Enrique F.
Thadhani, Ravi
Sachs, Benjamin P.
Sukhatme, Vikas P.
Karumanchi, S. Ananth
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-02-12
Volume: 350
Issue: 7
Pages: 672-683
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa031884
OpenAlex: W2081255404
Cited by: 3,720
References: 24
Citations by year: 2026: 148 · 2025: 165 · 2024: 142 · 2023: 152 · 2022: 207 · 2021: 180 · 2020: 170 · 2019: 182 · 2018: 185 · 2017: 229 · 2016: 201 · 2015: 171 · 2014: 193 · 2013: 199 · 2012: 185
FWCI: 122.15
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords: preeclampsia, soluble fms-like tyrosine kinase-1, placental growth factor, vascular endothelial growth factor, angiogenic factors, serum biomarkers, preeclampsia risk prediction, small for gestational age, nulliparous women
MeSH terms: Placenta Growth Factor, Adult, Cross-Sectional Studies, Female, Gestational Age, Humans, Pre-Eclampsia, Pregnancy, Pregnancy Proteins, Risk Factors, Biomarkers, Body Mass Index, Logistic Models, Odds Ratio, Case-Control Studies, Statistics, Nonparametric, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating Angiogenic Factors and the Risk of Preeclampsia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks